Serotype Distribution in Hospitalized Adult With Pneumococcal Community Acquired Pneumonia in France

NCT05380193 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1017

Last updated 2025-05-15

No results posted yet for this study

Summary

CAP'Hospi is an observational, multicentric study in France which primary objective is to describe the proportion of Community Acquired Pneumonia due to serotypes included in PCV20 among adults hospitalized for CAP

Conditions

  • Pneumonia
  • Pneumococcal Infections
  • Community-acquired Pneumonia

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Principal Investigators

  • Liem B Luong, MD · CIC 1417 Cochin-Pasteur

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-09
Primary Completion
2025-02-06
Completion
2025-02-06

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05380193 on ClinicalTrials.gov